Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Little Evidence Shows Cannabis Helps Chronic Pain or PTSD

Lisa Rapaport  |  August 16, 2017

One area researchers are exploring is the use of cannabis to help ease mental health problems that can lead to suicide among veterans. Other conditions cannabis is used for include nausea, epilepsy, and traumatic brain injury.

Several countries, but not the U.S., have approved a cannabis-based drug to treat painful muscle spasms from multiple sclerosis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

It’s possible one group of cannabinoids may be responsible for both the high experienced by recreational users and the pain relief seen in some studies, said Dr. Winfried Hauser, a pain specialist at Klinikum Saarbrucken in Germany who wasn’t involved in the current studies.

Even though cannabis is legal for medical use in Germany, Hauser says many doctors hesitate to prescribe it because there aren’t well-defined recommended doses available. Vaporizers are difficult for many patients, and cannabis smoked in combination with tobacco can have dangerous side effects, Hauser adds.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Medical cannabis is no magic pill,” Hauser says.


References

  1. Nugent SM, Morasco BJ, O’Neil ME, et al. The effects of cannabis among adults with chronic pain and an overview of general harms: A systematic review. Ann Intern Med. 2017 Aug 15. doi: 10.7326/M17-0155. [Epub ahead of print]
  2. O’Neil ME, Nugent SM, Morasco BJ, et al. Benefits and harms of plant-based cannabis for post traumatic stress disorder: A systematic review. Ann Intern Med. 2017 Aug 15. doi: 10.7326/M17-0477. [Epub ahead of print]
  3. The White House. Office of the press secretary. News release: Press briefing by Sec. of Veterans Affairs David Shulkin. 2017 May 13.

Page: 1 2 | Single Page
Share: 

Filed under:AnalgesicsConditionsDrug UpdatesPain Syndromes Tagged with:cannabisChronic painmarijuanaPainPain ManagementPost-Traumatic Stress Disorder (PTSD)

Related Articles

    Cannabis in Rheumatology Care: A Look at the Latest Research & What Rheumatologists Are Telling Their Patients

    March 26, 2018

    As medical and recreational marijuana becomes more accessible, researchers seek creative ways to study the cannabis plant and explore the complexities of the endocannabinoid system in pain relief. Rheumatologists currently face an influx of patients asking if marijuana can help them. Here’s a look at the evolving research on cannabinoids for rheumatologic pain management and how doctors are discussing it with their patients…

    Cannabis for Pain Relief: An Area Ripe for Research

    September 28, 2023

    Medical cannabis may benefit patients experiencing pain, and rheumatologists should be able to discuss its potential risks and benefits with their patients. Here are insights from Dr. Mary Ann Fitzcharles on current research, patient use and more.

    Brandon Crawford / shutterstock.com

    Case Report: Blunt Smoker Denies Tobacco Use, Delaying Diagnosis

    May 12, 2022

    Cannabis arteritis mirrors thrombo­angiitis obliterans in its clinical and arteriographic presentation, but its relevant exposure is cannabis rather than tobacco.1 Whether cannabis arteritis is a subset of thromboangiitis obliterans or a unique pathologic entity is debatable. Delta-9-tetrahydrocannabinol, the primary psychoactive component of cannabis, is a peripheral vasoconstrictor.2 This offers mechanistic insight into how cannabis may…

    Cannabinoids Show Potential in Pain Management

    February 13, 2020

    ATLANTA—The potential of cannabis‐based medicines is a hot topic, particularly as pain management therapy for arthritis and other conditions. However, confusion abounds regarding its therapeutic potential, how it can be administered and even the correct terminology to use. David P. Finn, PhD, professor of pharma­cology and therapeutics, and founding co-director of the Centre for Pain…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences